Literature DB >> 21514080

Estimation of liver function using T2* mapping on gadolinium ethoxybenzyl diethylenetriamine pentaacetic acid enhanced magnetic resonance imaging.

Takashi Katsube1, Masahiro Okada, Seishi Kumano, Izumi Imaoka, Yuki Kagawa, Masatoshi Hori, Kazunari Ishii, Noboru Tanigawa, Yasuharu Imai, Masatoshi Kudo, Takamichi Murakami.   

Abstract

PURPOSE: To investigate the usefulness of T2* mapping of liver on gadolinium ethoxybenzyl diethylenetriamine pentaacetic acid (Gd-EOB-DTPA)-enhanced MRI for estimating liver function.
MATERIALS AND METHODS: 33 patients were classified into 3 groups as follows: normal liver function (NLF) (n = 7); mild liver damage (MLD) (n = 16) with Child-Pugh A; severe liver damage (SLD) (n = 10) with Child-Pugh B. T2*-weighted gradient-echo (T2*W-GRE) and T1-weighted gradient-echo (T1W-GRE) images were obtained before and after Gd-EOB-DTPA administration (3, 8, 13, and 18 min; 5, 10,15, and 20min; respectively). T2* mapping of liver was calculated from T2*W-GRE, then T2* values of liver and T2* reduction rates of T2* value between pre- and post-contrast enhancement were measured. The increase rates of liver-to-muscle signal intensity (LMS) ratio on T1W-GRE between pre- and post-contrast enhancement were calculated.
RESULTS: T2* values on pre- and post-contrast showed no significant differences among three groups. Significant differences in T2* reduction rates were found among groups, and those of LCB were lower than those of other groups (NLF:MLD:SLD, 3.8:6.0:0.6% at 3 min, 8.2:10.3:1.0% at 8 min, 10.7:11.5:1.2% at 13 min, and 16.1:13.2:3.5% at 18 min, respectively) (P<0.05). Significant differences in increase rates of LMS ratio on T1W-GRE were identified (NLF:MLD:SLD, 1.53:1.46:1.35 at 5 min, 1.68:1.64:1.37 at 10 min, 1.79:1.76:1.44 at 15 min, and 1.89:1.78:1.49 at 20 min, respectively).
CONCLUSION: T2* reduction rate and increase rate of LMS ratio on T1W-GRE may allow us estimation of liver function according to Child-Pugh score.
Copyright © 2011 Elsevier Ireland Ltd. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21514080     DOI: 10.1016/j.ejrad.2011.03.073

Source DB:  PubMed          Journal:  Eur J Radiol        ISSN: 0720-048X            Impact factor:   3.528


  9 in total

1.  Chronological evaluation of liver enhancement in patients with chronic liver disease at Gd-EOB-DTPA-enhanced 3-T MR imaging: does liver function correlate with enhancement?

Authors:  Shinichi Nakamura; Kazuo Awai; Daisuke Utsunomiya; Tomohiro Namimoto; Takeshi Nakaura; Kosuke Morita; Yasuyuki Yamashita
Journal:  Jpn J Radiol       Date:  2011-12-14       Impact factor: 2.374

2.  Gadolinium-ethoxybenzyl-diethylenetriamine penta-acetic acid-enhanced magnetic resonance imaging for evaluating fibrosis regression in chronic hepatitis C patients after direct-acting antiviral.

Authors:  Xiao-He Li; Rui Huang; Ming Yang; Jian Wang; Ying-Hui Gao; Qian Jin; Dan-Li Ma; Lai Wei; Hui-Ying Rao
Journal:  World J Gastroenterol       Date:  2022-05-28       Impact factor: 5.374

3.  Usefulness of T1 mapping on Gd-EOB-DTPA-enhanced MR imaging in assessment of non-alcoholic fatty liver disease.

Authors:  Ying Ding; Sheng-Xiang Rao; Tao Meng; Caizhong Chen; Renchen Li; Meng-Su Zeng
Journal:  Eur Radiol       Date:  2014-01-26       Impact factor: 5.315

4.  Age dependence of spleen- and muscle-corrected hepatic signal enhancement on hepatobiliary phase gadoxetate MRI.

Authors:  Simon Matoori; Johannes M Froehlich; Stefan Breitenstein; Aleksis Doert; Viktoria Pozdniakova; Dow-Mu Koh; Andreas Gutzeit
Journal:  Eur Radiol       Date:  2015-09-03       Impact factor: 5.315

5.  Consensus report from the 7th International Forum for Liver Magnetic Resonance Imaging.

Authors:  Elmar M Merkle; Christoph J Zech; Carlo Bartolozzi; Mustafa R Bashir; Ahmed Ba-Ssalamah; Alexander Huppertz; Jeong Min Lee; Jens Ricke; Michiie Sakamoto; Claude B Sirlin; Sheng-Long Ye; Mengsu Zeng
Journal:  Eur Radiol       Date:  2015-06-13       Impact factor: 5.315

6.  Development of a novel rat model of heterogeneous hepatic injury by injection with colchicine via the splenic vein.

Authors:  Yan-Yan Zhang; Chao-Xu Zhang; Yu Li; Xuan Jiang; Yong-Fang Wang; Yang Sun; Jun Wang; Wan-Ying Ji; Yi Liu
Journal:  World J Gastroenterol       Date:  2018-11-28       Impact factor: 5.742

7.  Gadoxetic acid disodium-enhanced magnetic resonance imaging for the detection of hepatocellular carcinoma: a meta-analysis.

Authors:  Xijiao Liu; Li Zou; Fei Liu; Yin Zhou; Bin Song
Journal:  PLoS One       Date:  2013-08-15       Impact factor: 3.240

8.  Gd-EOB-DTPA-enhanced magnetic resonance imaging combined with T1 mapping predicts the degree of differentiation in hepatocellular carcinoma.

Authors:  Zhenpeng Peng; Mengjie Jiang; Huasong Cai; Tao Chan; Zhi Dong; Yanji Luo; Zi-Ping Li; Shi-Ting Feng
Journal:  BMC Cancer       Date:  2016-08-12       Impact factor: 4.430

9.  T2* Mapping from Multi-Echo Dixon Sequence on Gadoxetic Acid-Enhanced Magnetic Resonance Imaging for the Hepatic Fat Quantification: Can It Be Used for Hepatic Function Assessment?

Authors:  Hyunsuk Yoo; Jeong Min Lee; Jeong Hee Yoon; Hyo-Jin Kang; Sang Min Lee; Hyun Kyung Yang; Joon Koo Han
Journal:  Korean J Radiol       Date:  2017-05-19       Impact factor: 3.500

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.